Biosynth is a CDMO of peptides based in USA / Netherlands. Direct manufacturer. Founded 2011. Key products include custom peptide synthesis, peptide modifications.
US + Netherlands-based CDMO. Custom peptide synthesis and modifications with global delivery capabilities. Offers wide range of peptide catalog products.
Biosynth is listed as a CDMO in the peptide supply chain, serving Global markets from USA / Netherlands. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.